We shown that, in contrast to classical opioid receptors, ACKR3 will not result in classical G protein signaling and is not modulated from the classical prescription or analgesic opioids, including morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists like naloxone. Instead, we established that LIH383, an ACKR3-selective subnanomolar https://hilairen638dxr1.blog-eye.com/profile